Relacorilant
Relacorilant
Relacorilant (pronounced: reh-luh-koh-ril-ant) is a glucocorticoid receptor antagonist that is currently under investigation for its potential therapeutic applications in the treatment of Cushing's syndrome and solid tumors.
Etymology
The term "Relacorilant" is a proprietary name given by the pharmaceutical company Corcept Therapeutics. The etymology of the term is not publicly disclosed.
Pharmacology
Relacorilant works by blocking the effects of cortisol, a hormone that can cause a variety of health problems when its levels are too high in the body. It does this by binding to the glucocorticoid receptor, preventing cortisol from attaching and exerting its effects.
Clinical Trials
Relacorilant has been tested in several clinical trials for its efficacy in treating Cushing's syndrome and solid tumors. The results of these trials have shown promise, but further research is needed to confirm its safety and effectiveness.
Related Terms
External links
- Medical encyclopedia article on Relacorilant
- Wikipedia's article - Relacorilant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski